Belgium’s Medaxes Appoints New Board
Also Plans Biosimilars Awareness Day Following Generics Event Last Year
Belgian industry association Medaxes has appointed a new board at the same time as revealing plans for a biosimilars awareness day in April, following in the footsteps of a recent initiative focused on generics.
You may also be interested in...
Belgium’s Medaxes off-patent industry association has run a Generic Medicines Day to raise public awareness of the benefits of generics, as well as the obstacles that the industry faces.
Increased uptake for generics and biosimilars must become Belgium’s “new normal” in the wake of the coronavirus crisis, local off-patent industry association Medaxes has argued.
Belgian off-patent industry association Medaxes has set out its aspirations for a new biosimilars taskforce that has been set up by local health insurance body INAMI. Data cited by the industry body shows that biosimilar penetration in Belgium is still lagging behind that of its European neighbors.